Nicolas Penet

Nicoals Penet

Nicolas has several years of experience in investment and research valorisation, particularly at INSAVALOR. His role as President of Pertinence Invest gives him a pragmatic vision of the first stages of financing the deeptech projects that M2care is looking for. Nicolas graduated from CPE Lyon, the University of Strasbourg and EMLyon. Passionate about technology transfer, […]

Florence THUEUX

Florence has a dual experience as an entrepreneur and an investor in the healthcare sector. She has participated in the start-up, development and sell out of several companies, in positions of CFO then CEO and President, in roles of growth structuring, negotiation of deals, architecture of business’ and equity’s partnerships, M&A, strategy and management (Arrow […]


Valérie began her career as a researcher in hematology and virology at the Institut National de la Recherche Médicale (INSERM). After collaborating on a Franco-American HIV research program at UC Davis, she joined Transgene SA, a subsidiary of Institut Mérieux specialized in gene therapy and immunotherapy. She then led a spin-off project in the cardiovascular […]

Célia HART

Celia has more than 15 years of private equity experience and has been at Supernova Invest since 2005 in charge of the early-stage team, the healthcare sector and the Supernova 2 fund. Prior to that, she held several senior positions at Cambridge Antibody Technology (Medimmune since its acquisition by Astra Zeneca), one of the UK’s […]